By: ICN Bureau
Last updated : October 23, 2026 7:46 pm
Speakers are Prof. V. N. Rajasekharan Pillai, Advisor & Professor of Eminence, Reliance Jio Institute; Dr. Richard Lobo, Global Head Business Excellence, Innovation, R&D | Chief Ethics Counselor, Tata Chemicals; Mr. Prasenjit Purkait, Head - R&D, Clariant IGL Specialty Chemicals and Satvik Kalra, Cofounder & COO, SarthhakAI and Pravin Prashant, Executive Editor of India Chemical News
The upcoming ChemPharma R&D Summit 2026, scheduled for October 27-28, 2026, is set to host a high-profile panel discussion addressing one of the most critical challenges facing the industry today: "R&D Pipeline Resiliency and Managing Cross-Border Regulatory Constraints."
Jointly organised by Indian Chemical News and Indian Pharma Post, the inaugural summit serves as a premier platform focusing on science-led innovation, advanced product development, and global IP creation within the chemical and pharmaceutical sectors.
The agenda of the Summit is available Here. One can register on the below given Link:
https://www.indianchemicalnews.com/chempharma_r_and_d_summit_2026//register.php
The session will bring together an esteemed lineup of thought leaders and industry stalwarts to deliberate on navigating geopolitical shifts and regulatory bottlenecks: Prof. V. N. Rajasekharan Pillai, Advisor & Professor of Eminence, Reliance Jio Institute; Dr. Richard Lobo, Global Head Business Excellence, Innovation, R&D | Chief Ethics Counselor, Tata Chemicals; Mr. Prasenjit Purkait, Head - R&D, Clariant IGL Specialty Chemicals and Satvik Kalra, Cofounder & COO, SarthhakAI. The session will be moderated by Pravin Prashant, Executive Editor of India Chemical News.
As global markets face rapid technological and regulatory fragmentation, the panel will dissect strategies to sustain robust innovation pipelines. The core discussion points include: Geographic Diversification & Supply Chain Integration, Harmonization vs. Fragmentation, IP Protection & Export Controls, Public-Private Collaborations and Regulatory Tech.
Faced with tightening trade policies and shifting geopolitical alliances, chemical and pharmaceutical companies must evolve beyond traditional risk management. This session promises to provide actionable blueprints for Indian and global enterprises aiming to build resilient, compliant, and future-proof R&D operations capable of thriving in a fractured global landscape.